Abstract
Although the risk of developing dysplasia and carcinomas in the colon is known to increase over time in patients with ulcerative colitis, data are scarce on the need for surveillance colonoscopies in patients with long-standing Crohn's colitis. This article discusses the results of a study by Friedman et al. conducted in 259 patients with chronic Crohn's colitis who received a median of four follow-up colonoscopies over 25 years after an initial negative examination result for dysplasia or carcinomas. The cumulative risk for developing dysplasia or carcinomas has only increased from 22% to 25% in the 10 years since the previous report from this study's authors, and the prevalence of extensive colitis was higher in study participants than that expected in a random population of patients with Crohn's colitis. However, Friedman et al. provide convincing evidence that long-term surveillance for the development of colonic dysplasia and cancers is advantageous in this population.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Friedman S et al. (2008) Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years. Clin Gastroenterol Hepatol 6: 993–998
Friedman S et al. (2001) Screening and surveillance colonoscopy in chronic Crohn colitis. Gastroenterology 120: 820–826
Woolrich AJ et al. (1992) Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology 103: 431–438
Butt JH et al. (1983) Macroscopic lesions in dysplasia and carcinoma complicating ulcerative colitis. Dig Dis Sci 28: 18–26
Hommes DW and van Deventer SJ (2004) Endoscopy in inflammatory bowel diseases. Gastroenterology 126: 1561–1573
Fefferman DS and Farrell RJ (2005) Endoscopy in inflammatory bowel disease: indications, surveillance and use in clinical practice. Clin Gastroenterol Hepatol 3: 11–24
Gupta RB et al. (2007) Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 133: 1099–1105
Korelitz BI et al. (1999) Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Am J Gastroenterol 94: 3248–3253
Gupta RB et al. (2007) Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 133: 1099–1105
Waye JD (1995) Endoscopy in inflammatory bowel disease. Inflammatory Bowel Disease, edn 4 555–582 (Eds Kirsner JB and Shorter RG) Philadelphia: Williams and Wilkins
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Korelitz, B. Crohn's colitis versus ulcerative colitis: should surveillance for dysplasia and cancer differ?. Nat Rev Gastroenterol Hepatol 6, 144–145 (2009). https://doi.org/10.1038/ncpgasthep1362
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ncpgasthep1362